Edition:
United Kingdom

Nektar Therapeutics (NKTR.OQ)

NKTR.OQ on NASDAQ Stock Exchange Global Select Market

56.90USD
15 Dec 2017
Change (% chg)

$1.85 (+3.36%)
Prev Close
$55.05
Open
$55.13
Day's High
$57.42
Day's Low
$55.13
Volume
2,010,509
Avg. Vol
624,399
52-wk High
$57.79
52-wk Low
$11.42

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 152.93 0.374
Jun '17 34.59 -0.385
Mar '17 24.73 -0.416
FY 2016 Dec '16 37.45 -0.283
Sep '16 36.34 -0.315
Jun '16 32.77 -0.356
Mar '16 58.88 -0.144
FY 2015 Dec '15 39.37 -0.403
Sep '15 59.95 -0.062
Jun '15 22.66 -0.400
Mar '15 108.80 0.249
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 8 40.31 48.10 37.52 52.55
Quarter Ending Mar-18 5 38.67 48.60 28.50 56.81
Year Ending Dec-17 8 252.51 260.30 249.76 206.47
Year Ending Dec-18 8 222.30 394.90 126.20 259.04
Earnings (per share)
Quarter Ending Dec-17 8 -0.33 -0.26 -0.40 -0.21
Quarter Ending Mar-18 6 -0.33 -0.25 -0.40 -0.12
Year Ending Dec-17 8 -0.74 -0.67 -0.81 -0.83
Year Ending Dec-18 8 -0.93 0.22 -1.58 -0.58
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 88.66 32.93
P/E High - Last 5 Yrs. -- 290.77 45.62
P/E Low - Last 5 Yrs. -- 93.67 24.34
Beta 1.38 0.85 0.88
Price to Sales (TTM) 29.14 100.68 5.40
Price to Book (MRQ) 1,142.03 13.50 5.38
Price to Tangible Book (MRQ) -- 13.43 6.78
Price to Cash Flow (TTM) -- 76.24 23.45
% Owned Institutions 98.26 6.25 1.40

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.50
Dividend Yield - 5 Year Avg -- 0.28 1.52
Dividend 5 Year Growth Rate -- 1.88 5.17
Payout Ratio(TTM) -- 17.26 43.76

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 5.56 433.88 9.00
Sales (TTM) vs TTM 1 Yr. Ago -30.30 75.04 5.38
Sales - 5 Yr. Growth Rate 18.27 33.47 10.33
EPS (MRQ) vs Qtr. 1 Yr. Ago -8.12 30.81 19.67
EPS (TTM) vs TTM 1 Yr. Ago -44.95 -- --
EPS - 5 Yr. Growth Rate -- 43.18 10.79
Capital Spending - 5 Yr. Growth Rate -8.04 40.71 15.25

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 3.82 1.68 2.18
Current Ratio (MRQ) 3.97 5.36 2.98
LT Debt to Equity (MRQ) 7,247.25 18.93 11.56
Total Debt to Equity (MRQ) 7,327.17 20.59 15.81
Interest Coverage (TTM) -1.84 -111.94 33.29

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 78.40 38.73 54.83
Gross Margin - 5 Yr. Avg. 80.44 51.18 52.40
EBITD Margin (TTM) -115.80 -- --
EBITD - 5 Yr. Avg -42.13 -261.13 15.24
Operating Margin (TTM) -127.82 -556.69 7.76
Operating Margin - 5 Yr. Avg. -52.49 -279.31 10.75
Pre-Tax Margin (TTM) -156.53 -529.93 8.57
Pre-Tax Margin - 5 Yr. Avg. -74.84 -279.05 11.17
Net Profit Margin (TTM) -157.14 -531.37 4.88
Net Profit Margin - 5 Yr. Avg. -75.27 -282.22 7.47
Effective Tax Rate (TTM) -- 23.72 23.11
Effective Tax Rate - 5 Yr. Avg. -- 19.13 24.00

Efficiency

  Company industry sector
Revenue/Employee (TTM) 284,412 25,316,769 864,680,848
Net Income/Employee (TTM) -446,923 3,332,346 101,718,394
Receivable Turnover (TTM) 8.35 21.54 5.76
Inventory Turnover (TTM) 2.70 2.01 3.34
Asset Turnover (TTM) 0.28 0.37 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -44.55 -0.77 11.00
Return on Assets - 5 Yr. Avg. -25.30 -0.26 12.43
Return on Investment (TTM) -53.15 2.36 14.46
Return on Investment - 5 Yr. Avg. -31.37 2.98 16.28
Return on Equity (TTM) -- 2.96 16.05
Return on Equity - 5 Yr. Avg. -435.78 6.41 17.51
  1 Year 3 Year 5 Year
Sales % -28.32 3.57 18.27
EPS (TTM) % -79.45 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Nektar Therapeutics

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 11.41 7.56 75 53
13 Week 25.37 19.26 81 60
26 Week 23.37 13.99 76 69
52 Week 45.94 23.70 76 46
YTD 102.20 77.57 90 50
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 93.16%
# of Holders: 289
Total Shares Held: 146,701,343
3 Mo. Net Change: -6,447,362
# New Positions: 29
# Closed Positions: 16
# Increased Positions: 128
# Reduced Positions: 97
# Net Buyers: 31
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.